Keywords: wuxi, enters, three-year, adme, analysis, accord, pfizer

Wuxi enters three-year ADME analysis accord with Pfizer

Article | 17 November 2008

Print This

WuXi PharmaTech, a drug R&D outsourcing company with operations in China and the USA, has signed a new three-year, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in